Dr Reddy's Laboratories Ltd

NYSE:RDYUnited States

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Contact Information

Headquarters

8-2-337, Road No.3 Banjara HillsHYDERABAD, India 500034

Phone

404-900-2900

Fax

404-900-2999

Executives

Chairman of the Board

Kallam Reddy

Co-Chairman of the Board, Managing Director

Gunupati Prasad

Chief Executive Officer

Erez Israeli

Chief Financial Officer

M. V. Narasimham

Chief Executive Officer, European Generics

Patrick Aghanian